Get started
CORCEPT THERAPEUTICS INCCORCEPT THERAPEUTICS INCCORCEPT THERAPEUTICS INC

CORCEPT THERAPEUTICS INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast

1CORT chart


Full chart

1CORT upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪7.21 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
66.94
Basic EPS (TTM)
1.18 EUR
Net income (FY)
‪134.98 M‬ EUR
Revenue (FY)
‪652.07 M‬ EUR
Shares float
‪93.77 M‬
Beta (1Y)
0.19

Employees


Employees (FY)
500
Change (1Y)
+148 +42.05%
Revenue / Employee (1Y)
‪1.30 M‬ EUR
Net income / Employee (1Y)
‪269.96 K‬ EUR

About Corcept Therapeutics Incorporated


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Joseph K. Belanoff
Website
corcept.com
Headquarters
Redwood City
Founded
1998
FIGI
BBG01TNXLB36
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1CORT news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Check out other big names from the same industry as 1CORT.

Frequently Asked Questions


The current price of 1CORT is 68.94 EUR — it has increased by 0.94% in the past 24 hours. Watch CORCEPT THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange CORCEPT THERAPEUTICS INC stocks are traded under the ticker 1CORT.
1CORT stock has risen by 1.68% compared to the previous week, the month change is a 8.81% rise, over the last year CORCEPT THERAPEUTICS INC has showed a 8.81% increase.
We've gathered analysts' opinions on CORCEPT THERAPEUTICS INC future price: according to them, 1CORT price has a max estimate of 127.51 EUR and a min estimate of 115.20 EUR. Watch 1CORT chart and read a more detailed CORCEPT THERAPEUTICS INC stock forecast: see what analysts think of CORCEPT THERAPEUTICS INC and suggest that you do with its stocks.
1CORT reached its all-time high on May 23, 2025 with the price of 68.04 EUR, and its all-time low was 62.20 EUR and was reached on May 14, 2025. View more price dynamics on 1CORT chart.
See other stocks reaching their highest and lowest prices.
1CORT stock is 0.93% volatile and has beta coefficient of 0.19. Track CORCEPT THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is CORCEPT THERAPEUTICS INC there?
Today CORCEPT THERAPEUTICS INC has the market capitalization of ‪7.29 B‬, it has increased by 1.31% over the last week.
Yes, you can track CORCEPT THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
CORCEPT THERAPEUTICS INC is going to release the next earnings report on Jul 30, 2025. Keep track of upcoming events with our Earnings Calendar.
1CORT earnings for the last quarter are 0.16 EUR per share, whereas the estimation was 0.13 EUR resulting in a 19.30% surprise. The estimated earnings for the next quarter are 0.17 EUR per share. See more details about CORCEPT THERAPEUTICS INC earnings.
CORCEPT THERAPEUTICS INC revenue for the last quarter amounts to ‪145.32 M‬ EUR, despite the estimated figure of ‪164.46 M‬ EUR. In the next quarter, revenue is expected to reach ‪176.58 M‬ EUR.
1CORT net income for the last quarter is ‪18.75 M‬ EUR, while the quarter before that showed ‪29.36 M‬ EUR of net income which accounts for −36.12% change. Track more CORCEPT THERAPEUTICS INC financial stats to get the full picture.
No, 1CORT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 29, 2025, the company has 500 employees. See our rating of the largest employees — is CORCEPT THERAPEUTICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CORCEPT THERAPEUTICS INC EBITDA is ‪104.03 M‬ EUR, and current EBITDA margin is 20.49%. See more stats in CORCEPT THERAPEUTICS INC financial statements.
Like other stocks, 1CORT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CORCEPT THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.